Smartphone-Supported Versus Regular Face-to-Face Behavioral Activation Treatment for Depression: a Randomized Controlled Non-Inferiority Trial
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
In light of the research support for behavioral activation, and the promising findings of smartphone-delivered psychological interventions in the treatment of depression, we evaluated a smartphone depression application as an adjunct to four face-to-face sessions (blended therapy) for mild to moderate depression. The blended therapy was compared to a full 10-session treatment with no support from a smartphone.
This was a non-inferiority study with unrestricted randomization in a 1:1 ratio. The study was conducted at three clinics in Sweden. 45 participants diagnosed with major depressive disorder received the blended treatment, and 43 participants received the full 10-session treatment. Main outcome measures were the BDI-II and the PHQ-9.
Results showed no significant interaction effects of group and time on any of the outcome measures neither from pre-treatment to post-treatment nor from pre-treatment to the 6-month follow up. The average therapist time per participant for the blended treatment was 291 minutes, which was a reduction of time with 44.6 % compared to the full 10-session program.
We assume that the reduction of sessions while still having the therapist highly involved in the treatment will have implications for the planning of psychological services. Moreover, from a theoretical point of view, the trial could be important as it tests the possibility to integrate modern information technology with face-to-face therapy.
Since the two treatments yielded equivalent outcomes and at the same time, the blended treatment reduced the therapist time with an average of 44.6 %, this could have important implications from a societal perspective.
This was a non-inferiority study with unrestricted randomization in a 1:1 ratio. The study was conducted at three clinics in Sweden. 45 participants diagnosed with major depressive disorder received the blended treatment, and 43 participants received the full 10-session treatment. Main outcome measures were the BDI-II and the PHQ-9.
Results showed no significant interaction effects of group and time on any of the outcome measures neither from pre-treatment to post-treatment nor from pre-treatment to the 6-month follow up. The average therapist time per participant for the blended treatment was 291 minutes, which was a reduction of time with 44.6 % compared to the full 10-session program.
We assume that the reduction of sessions while still having the therapist highly involved in the treatment will have implications for the planning of psychological services. Moreover, from a theoretical point of view, the trial could be important as it tests the possibility to integrate modern information technology with face-to-face therapy.
Since the two treatments yielded equivalent outcomes and at the same time, the blended treatment reduced the therapist time with an average of 44.6 %, this could have important implications from a societal perspective.
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
This work is licensed under a Creative Commons Attribution 3.0 License.